XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 151 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,071,666 | -11.4% | 236,290 | -0.2% | 0.29% | +2.9% |
| Q2 2023 | $9,114,991 | -7.7% | 236,753 | -14.2% | 0.28% | -7.0% |
| Q1 2023 | $9,878,469 | -22.7% | 276,012 | -14.9% | 0.30% | -23.0% |
| Q4 2022 | $12,785,178 | +18.1% | 324,250 | +8.1% | 0.39% | +10.8% |
| Q3 2022 | $10,825,000 | +25.0% | 299,855 | +5.3% | 0.35% | +19.3% |
| Q2 2022 | $8,663,000 | +7.9% | 284,772 | +8.4% | 0.30% | +48.7% |
| Q1 2022 | $8,031,000 | +18.3% | 262,705 | +20.9% | 0.20% | +42.1% |
| Q4 2021 | $6,788,000 | +429.9% | 217,301 | +159.1% | 0.14% | +483.3% |
| Q3 2021 | $1,281,000 | -17.4% | 83,854 | +0.7% | 0.02% | -17.2% |
| Q2 2021 | $1,550,000 | +4.2% | 83,249 | +0.2% | 0.03% | -9.4% |
| Q1 2021 | $1,487,000 | -36.9% | 83,088 | -45.8% | 0.03% | -39.6% |
| Q4 2020 | $2,358,000 | +34.2% | 153,321 | -3.4% | 0.05% | -11.7% |
| Q3 2020 | $1,757,000 | +26.2% | 158,704 | +43.0% | 0.06% | +20.0% |
| Q2 2020 | $1,392,000 | +10.6% | 110,999 | 0.0% | 0.05% | -26.5% |
| Q1 2020 | $1,259,000 | -10.1% | 110,999 | +3.9% | 0.07% | +6.2% |
| Q4 2019 | $1,401,000 | +46.1% | 106,839 | +0.4% | 0.06% | +20.8% |
| Q3 2019 | $959,000 | -1.0% | 106,459 | +8.3% | 0.05% | +10.4% |
| Q2 2019 | $969,000 | -12.2% | 98,259 | -9.6% | 0.05% | -18.6% |
| Q1 2019 | $1,104,000 | – | 108,679 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $57,577,000 | 9.26% |
| GREAT POINT PARTNERS LLC | 850,000 | $30,685,000 | 7.39% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $9,837,000 | 4.24% |
| DAFNA Capital Management LLC | 375,223 | $13,546,000 | 3.64% |
| Redmile Group, LLC | 2,370,614 | $85,579,000 | 3.32% |
| Avoro Capital Advisors LLC | 4,900,000 | $176,890,000 | 3.27% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 245,992 | $8,880,000 | 3.00% |
| Nan Fung Group Holdings Ltd | 114,380 | $4,129,000 | 2.64% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,504,020 | $162,595,000 | 2.46% |
| Parkman Healthcare Partners LLC | 222,597 | $8,036,000 | 2.28% |